• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加利福尼亚高级执业药师的实施以及分级许可制持续令人失望的情况。

Implementation of the California advanced practice pharmacist and the continued disappointment of tiered licensure.

作者信息

Adams Alex J, Frost Tim P

机构信息

Idaho Division of Financial Management, Eagle, ID 83616, USA.

Idaho Division of Occupational and Professional Licenses, Boise, ID, USA.

出版信息

Explor Res Clin Soc Pharm. 2023 Oct 20;12:100353. doi: 10.1016/j.rcsop.2023.100353. eCollection 2023 Dec.

DOI:10.1016/j.rcsop.2023.100353
PMID:37965248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10641243/
Abstract

The Advanced Practice Pharmacist (APh) designation in California was created via legislation 10 years ago. California pharmacists who meet certain criteria can be designated as an APh and unlock additional practice authority. Just 1065 pharmacists, or 2% of licensed California pharmacists, have obtained the APh designation through 2022. APhs did not report benefiting from the designation as it relates to expanded scope of practice. This experience of low uptake and minimal benefit mirrors the tiered licenses created by three other states. More recent legislation broadened the independent prescriptive authority of APhs, but this increased value proposition aligns with the practice authority adopted by other states who have imposed fewer barriers to entry. Given the track record observed to date, we doubt that tiered licensure will ever prove successful in the pharmacy profession. Instead, state policymakers and pharmacy advocates should consider adopting a "standard of care" regulatory approach to improve patient access to safe and beneficial pharmacist services.

摘要

加利福尼亚州的高级执业药师(APh)资格是10年前通过立法设立的。符合特定标准的加利福尼亚州药剂师可被指定为APh,并获得额外的执业权限。截至2022年,只有1065名药剂师(占加利福尼亚州持牌药剂师的2%)获得了APh资格。APh并未报告称因该资格与扩大的执业范围相关而从中受益。这种低接受率和极少受益的情况反映了其他三个州设立的分级执照的情况。最近的立法扩大了APh的独立处方权,但这种增加的价值主张与其他对准入限制较少的州所采用的执业权限相一致。鉴于迄今为止观察到的记录,我们怀疑分级执照在药学专业中是否会成功。相反,州政策制定者和药学倡导者应考虑采用“护理标准”监管方法,以改善患者获得安全有益的药剂师服务的机会。

相似文献

1
Implementation of the California advanced practice pharmacist and the continued disappointment of tiered licensure.加利福尼亚高级执业药师的实施以及分级许可制持续令人失望的情况。
Explor Res Clin Soc Pharm. 2023 Oct 20;12:100353. doi: 10.1016/j.rcsop.2023.100353. eCollection 2023 Dec.
2
Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.在努力扩大特定药师自主处方权限的过程中,研究证据的使用存在差异:评估和建议以增加研究的利用。
Health Res Policy Syst. 2022 Jan 3;20(1):1. doi: 10.1186/s12961-021-00789-9.
3
Are advanced practice pharmacist designations really advanced?高级实践药剂师的称号真的高级吗?
Res Social Adm Pharm. 2018 May;14(5):501-504. doi: 10.1016/j.sapharm.2017.10.002. Epub 2017 Oct 7.
4
Pathways to pharmacist prescriptive authority: Do decentralized models for expanded prescribing work?药剂师处方权限的途径:扩大处方的分散模式是否有效?
Res Social Adm Pharm. 2022 Apr;18(4):2695-2699. doi: 10.1016/j.sapharm.2021.07.016. Epub 2021 Jul 17.
5
Impact of credentialing and provider privileges on clinical interventions made by advanced practice pharmacists in California.加利福尼亚州认证和提供者特权对高级执业药师进行的临床干预的影响。
J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):663-668. doi: 10.1016/j.japh.2020.02.016. Epub 2020 May 22.
6
The Continuum of Pharmacist Prescriptive Authority.药剂师处方权的连续性
Ann Pharmacother. 2016 Sep;50(9):778-84. doi: 10.1177/1060028016653608. Epub 2016 Jun 15.
7
Tiered Licensure for Pharmacy Technicians: Is the Advanced Pharmacy Technician (APhT) License the Model for State Regulators?药学技术人员的分级许可:高级药学技术人员(APhT)许可证是州监管机构的典范吗?
J Pharm Technol. 2024 Aug;40(4):202-206. doi: 10.1177/87551225241247687. Epub 2024 May 6.
8
9
Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia.不列颠哥伦比亚省北部卫生当局及社区药剂师对独立药剂师处方权的认知
Pharmacy (Basel). 2021 Apr 23;9(2):92. doi: 10.3390/pharmacy9020092.
10
Pharmacist-led Smoking-Cessation Services in the United States - A Multijurisdictional Legal Analysis.美国药剂师主导的戒烟服务——多辖区法律分析
Innov Pharm. 2022 Apr 2;13(1). doi: 10.24926/iip.v13i1.4643. eCollection 2022.

引用本文的文献

1
Tiered Licensure for Pharmacy Technicians: Is the Advanced Pharmacy Technician (APhT) License the Model for State Regulators?药学技术人员的分级许可:高级药学技术人员(APhT)许可证是州监管机构的典范吗?
J Pharm Technol. 2024 Aug;40(4):202-206. doi: 10.1177/87551225241247687. Epub 2024 May 6.

本文引用的文献

1
Identifying Services Provided in Community Pharmacy Practice Settings.识别社区药房实践环境中提供的服务。
Innov Pharm. 2023 Nov 9;14(3). doi: 10.24926/iip.v14i3.5543. eCollection 2023.
2
Regulating pharmacist services: Achieving a full scope of practice.规范药剂师服务:实现全面执业范围。
Can Pharm J (Ott). 2023 Jul 25;156(5):231-234. doi: 10.1177/17151635231188330. eCollection 2023 Sep-Oct.
3
Regulating Pharmacist Clinical Services: Is Legal Silence Golden or Deafening?规范药师临床服务:法律沉默是金还是无声?
J Pharm Pract. 2024 Aug;37(4):810-813. doi: 10.1177/08971900231199283. Epub 2023 Aug 30.
4
Revisiting the continuum of pharmacist prescriptive authority.重新审视药剂师处方权的连续统一体。
J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1508-1514. doi: 10.1016/j.japh.2023.06.025. Epub 2023 Jul 5.
5
Opportunities for pharmacist prescriptive authority of buprenorphine following passage of the Mainstreaming Addiction Treatment (MAT) Act.《成瘾治疗主流化(MAT)法案》通过后,药剂师对丁丙诺啡的处方权机会。
J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1495-1499. doi: 10.1016/j.japh.2023.06.001. Epub 2023 Jun 7.
6
Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?联邦药剂师开具帕罗韦德(Paxlovid)的处方权:一项模范政策还是优化治疗的障碍?
Explor Res Clin Soc Pharm. 2023 Mar;9:100244. doi: 10.1016/j.rcsop.2023.100244. Epub 2023 Mar 14.
7
Facilitating multistate pharmacy practice: Streamlining continuing pharmacy education requirements.促进多州药房实践:简化继续教育要求。
J Am Pharm Assoc (2003). 2023 May-Jun;63(3):731-735. doi: 10.1016/j.japh.2023.02.013. Epub 2023 Feb 14.
8
Pharmacy-Based Point-of-Care Testing: How a "Standard of Care" Approach Can Facilitate Sustainability.基于药房的即时检验:“医疗护理标准”方法如何促进可持续性。
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4290. eCollection 2021.
9
Pathways to pharmacist prescriptive authority: Do decentralized models for expanded prescribing work?药剂师处方权限的途径:扩大处方的分散模式是否有效?
Res Social Adm Pharm. 2022 Apr;18(4):2695-2699. doi: 10.1016/j.sapharm.2021.07.016. Epub 2021 Jul 17.
10
Pharmacy-Based Assessment and Management of Herpes Labialis (Cold Sores) with Antiviral Therapy.基于药房的唇疱疹(唇疮疹)抗病毒治疗评估与管理
Innov Pharm. 2020 Jul 31;11(3). doi: 10.24926/iip.v11i3.1532. eCollection 2020.